Prevalence of total hip replacement: how much demand has been met?

Williams, Mark; Newton, J.O.; Frankel, Stephen; Braddon, Fem; Barclay, Eliza; Gray, JC

doi:10.1136/jech.48.2.188

Cited by 22 publications

(8 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In one report [9], evaluating a population from Spain of older individuals ( n = 7577) using a validated screening questionnaire, the estimated rate for hip replacement was 38% among men surveyed with osteoarthritis. In another report, from the United Kingdom [4], the overall risk in a random surveyed cohort of 7806 patients for elective total hip replacement was 5.3%, similar to the overall risk observed in our population. Davenport et al [5] reported on the incidence of hip fractures in the Medicare population from 1992 to 1996.…”

Section: Discussionsupporting

confidence: 88%

“…Several reports have noted the incidence of hip fractures or hip-replacement surgery in the elderly population, citing incidences of 3–6% [4–8]. In one report [9], evaluating a population from Spain of older individuals ( n = 7577) using a validated screening questionnaire, the estimated rate for hip replacement was 38% among men surveyed with osteoarthritis.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Hip-related toxicity after prostate radiotherapy: Treatment related or coincidental?

Zeléfsky

Gorshein

Pei

et al. 2016

Radiotherapy and Oncology

View full text Add to dashboard Cite

Background and purpose To evaluate the incidence and predictors of hip toxicity postradiotherapy for localized prostate cancer. Methods and materials 4067 prostate cancer patients were treated with external beam radiotherapy (EBRT; n = 2569; 63%) or brachytherapy with or without supplemental EBRT (n = 1508; 27%). 43% (n = 1738) were treated with neo-adjuvant and concurrent ADT and 57% (n = 2329) with radiotherapy alone. Hip toxicity was defined as moderate or severe pain upon ambulation with or without the need for hip-revision surgery. Median follow-up was 7 years (range, 3–21 years). Results One hundred twenty-one (2.7%) patients developed moderate-to-severe hip pain after radiotherapy affecting ambulation. Of these, 73 (60%) required hip replacement secondary to persistent hip pain. Among patients with baseline degenerative joint disease (DJD) changes on scans, 10-year incidence of hip-related toxicity was 11% versus 3% for those without such changes (P < .001). The only variables on multivariate analysis associated with hip-related toxicity post-radiotherapy were baseline DJD on imaging (P < .0001) and prolonged ADT for salvage therapy (P < .0001). Conclusions Prostate EBRT or brachytherapy is associated with low incidence of long-term hip-related toxicity. The only variables identified associated with hip toxicity posttherapy was the presence of baseline DJD and prolonged salvage ADT posttreatment for patients developing recurrence.

show abstract

Section: Discussionsupporting

confidence: 88%

Section: Discussionmentioning

confidence: 99%

Hip-related toxicity after prostate radiotherapy: Treatment related or coincidental?

Zeléfsky

Gorshein

Pei

et al. 2016

Radiotherapy and Oncology

View full text Add to dashboard Cite

show abstract

“…This is in contrast to the wealth of information for shoulder prostheses in the US, 1,2 and the information available in the UK and US on total knee (TKR) and total hip replacement (THR). [3][4][5][6][7] Epidemiological studies have documented wide-spread and persistent variations in the indications for surgical procedures. 8 In orthopaedic practice, there is variation in the indications for several types of operative intervention, including total hip and total knee arthroplasty.…”

mentioning

confidence: 99%

Utilisation of shoulder arthroplasty in the UK

Ravenscroft¹,

Calvert²

2004

Ann R Coll Surg Engl

View full text Add to dashboard Cite

Aims:To estimate the per capita utilisation of shoulder prostheses in the UK and to compare UK figures to those from the US. Methods: A postal and telephone survey was undertaken of all hospitals in the UK carrying out orthopaedic operations. The relative usage of total shoulder replacement and hemi-arthroplasty for both elective and trauma indications were analysed and UK figures compared to those from the US. Results: There were 281 replies from 314 questionnaires, a response rate of 90%. The per capita rate of shoulder replacement is approximately one-tenth for total replacement and one-fifth for hemiarthroplasty compared to the US, suggesting that there is an unmet demand in the UK. In the US, the proportion of total replacements to hemi-arthroplasties for elective indications is approximately equal whereas in the UK there are twice as many hemi-arthroplasties, which raises the question as to whether hemi-arthroplasties are being used when a total replacement might be preferable. The numbers of shoulder arthroplasties implanted by individual surgeons and units is, except for a few large centres, small. Consequently, it is much more difficult for the surgeon to evaluate the various prosthetic designs and surgical techniques. Conclusion: There is a need for a national register to increase the knowledge about such designs and techniques and to analyse risk factors.

show abstract

“…At a micro level, there appears to be no simple relationship between admissions from the waiting list and the length of the list (Goldacre et al 1987;Henderson et al 1995). Others, such as Williams et al (1994), argue that the pool of unmet need may be smaller than previous estimates suggested. The common feature of all these studies is thatÐusually because of data limitationsÐthey can only model a part of the system.…”

Section: Nhs Waiting Listsmentioning

confidence: 80%